ABS acquires Cureline
ABS agreed to acquire Cureline. Reported deal value: Undisclosed. Status: Announced. Sector: biopharmaceutical. Target headquarters context: South San Francisco, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.
January 6,2026 — ABS Bio , Inc. , a leader in biospecimen sourcing, cellculture services and biorepository solutions for the global pharmaceutical andbiotechnology industry, today announced the acquisition of Cureline , Inc. , aSouth San Francisco , California -based provider of specimen procurement andhistology services
Deal timeline
This transaction is classified in biopharmaceutical. Figures and status may change as sources update.